The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials
Open accessThe DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed psychiatric disorders in childhood. A wide variety of treatments have been used for the management of ADHD. We aimed to compare the efficacy and safety of pharmacological, psychological and complementary and alternative medicine interventions for the treatment of ADHD in children and adolescents. METHODS AND FINDINGS: We performed a systematic review with network meta-analyses. Randomised controlled trials (≥ 3 weeks follow-up) were identified from published and unpublished sources through searches in PubMed and the Cochrane Library (up to April 7, 2016). Interventions of interest were pharmacological (stimulants, non-stimulants, antidepressants, antipsychotics, and other unlicensed drugs), psychological (behavioural, cognitive training and neurofeedback) and complementary and alternative medicine (dietary therapy, fatty acids, amino acids, minerals, herbal therapy, homeopathy, and physical activity). The primary outcomes were efficacy (treatment response) and acceptability (all-cause discontinuation). Secondary outcomes included discontinuation due to adverse events (tolerability), as well as serious adverse events and specific adverse events. Random-effects Bayesian network meta-analyses were conducted to obtain estimates as odds ratios (ORs) with 95% credibility intervals. We analysed interventions by class and individually. 190 randomised trials (52 different interventions grouped in 32 therapeutic classes) that enrolled 26114 participants with ADHD were included in complex networks. At the class level, behavioural therapy (alone or in combination with stimulants), stimulants, and non-stimulant seemed significantly more efficacious than placebo. Behavioural therapy in combination with stimulants seemed superior to stimulants or non-stimulants. Stimulants seemed superior to behavioural therapy, cognitive training and non-stimulants. Behavioural therapy, stimulants and their combination showed the best profile of acceptability. Stimulants and non-stimulants seemed well tolerated. Among medications, methylphenidate, amphetamine, atomoxetine, guanfacine and clonidine seemed significantly more efficacious than placebo. Methylphenidate and amphetamine seemed more efficacious than atomoxetine and guanfacine. Methylphenidate and clonidine seemed better accepted than placebo and atomoxetine. Most of the efficacious pharmacological treatments were associated with harms (anorexia, weight loss and insomnia), but an increased risk of serious adverse events was not observed. There is lack of evidence for cognitive training, neurofeedback, antidepressants, antipsychotics, dietary therapy, fatty acids, and other complementary and alternative medicine. Overall findings were limited by the clinical and methodological heterogeneity, small sample sizes of trials, short-term follow-up, and the absence of high-quality evidence; consequently, results should be interpreted with caution. CONCLUSIONS: Clinical differences may exist between the pharmacological and non-pharmacological treatment used for the management of ADHD. Uncertainties about therapies and the balance between benefits, costs and potential harms should be considered before starting treatment. There is an urgent need for high-quality randomised trials of the multiple treatments for ADHD in children and adolescents. PROSPERO, number CRD42014015008.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“A systematic review by Catalá-López et al. [180] supports their efficacy in children, though evidence in adults remains less conclusive.”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [180]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have consistently demonstrated that stimulant medications are more effective than behavioral therapy or cognitive training alone in reducing symptoms [112].”
From The Impact of Social Media & Technology on Child and Adolescent Mental Health (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Research indicates that non-stimulants are less effective than stimulant medications but can be useful for specific cases where stimulants are not suitable [112].”
From The Impact of Social Media & Technology on Child and Adolescent Mental Health (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Atomoxetine, a selective norepinephrine reuptake inhibitor, has been found to reduce symptoms, though it typically takes longer to achieve noticeable effects compared to stimulants [112].”
From The Impact of Social Media & Technology on Child and Adolescent Mental Health (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Two others, one combining twenty studies with over 3,000 participants, and another combining 37 studies with over 3,800 participants, found no increase in risk of all-cause treatment discontinuation in youths (Catala-Lopez et al., 2017; Schwartz and Correll, 2014).”
From The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder (2021) · cites this paper as Catala-Lopez et al., 2017
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Self-citationDermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Inference from iterative simulation using multiple sequences
Gelman, A., & Rubin, D. B. (1992) · Statistical Science · doi:10.1214/ss/1177011136 · Cited by 16,627
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Self-citationVos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Self-citationGRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
Hutton, B., Salanti, G., Caldwell, D. M., Chaimani, A., Schmid, C. H., Cameron, C., Ioannidis, J. P. A., Straus, S., Thorlund, K., Jansen, J. P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2385 · Cited by 8,269
Self-citation
Research works printed but not linked: 2
- Attention Deficit Hyperactivity Disorder. The NICE guideline on diagnosis and management of ADHD in children, young people and adults. Leicester (UK): The British Psychological Society and The Royal College of Psychiatrists; 2009. 22420012
- Gøtzsche PC. Comments on the editorial by Sterne JA “Why the Cochrane risk of bias tool should not include funding source as a standard item”. Cochrane Library 2014 http://www.cochranelibrary.com/editorial/10.1002/14651858.ED000076 (accessed June, 2017) · DOI · Paper page
Cited by
Items 101–200 of 396
Tao, Y., Li, H., Li, L., Zhang, H., Xu, H., Zhang, H., Zou, S., Deng, F., Huang, L., Wang, Y., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.01.057 · Cited by 27
Alsalemi, N., Sadowski, C. A., Elftouh, N., Louis, M., Kilpatrick, K., Houle, S. K. D., & Lafrance, J. (2022) · BMC Nephrology · doi:10.1186/s12882-022-02763-1 · Cited by 23
Kollins, S. H. (2018) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2018.1642 · Cited by 19
Primary care provision for young people with ADHD: a multi-perspective qualitative study
Gudka, R., Becker, K., Ward, J., Smith, J. R., Mughal, F., Meléndez‐Torres, G. J., Newlove‐Delgado, T., & Price, A. (2024) · British Journal of General Practice · doi:10.3399/bjgp.2023.0626 · Cited by 21
The efficacy of Ritalin in ADHD children under neurofeedback training
Pakdaman, F., Irani, F., Tajikzadeh, F., & Jabalkandi, S. A. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3539-3 · Cited by 21
General principles for psychotherapeutic interventions in children and adolescents
Chakraborty, K., & Bhide, A. (2020) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_811_19 · Cited by 19
Robe, A., & Dobrean, A. (2022) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-022-02005-7 · Cited by 26
Tourette syndrome and other tic disorders of childhood
Nilles, C., Hartmann, A., Roze, E. F., Martino, D., & Pringsheim, T. M. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98817-9.00002-8 · Cited by 19
Young, J. W., Roberts, B. Z., Breier, M. R., & Swerdlow, N. R. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05511-1 · Cited by 18
Yan, L., Wang, S., Yuan, Y., & Zhang, J. (2019) · Evidence-Based Mental Health · doi:10.1136/ebmental-2019-300088 · Cited by 18
Buchanan, D., D'Angiulli, A., Samson, A., Maisonneuve, A. R., & Robaey, P. (2020) · Journal of Health Psychology · doi:10.1177/1359105320937059 · Cited by 18
Yang, X., Zhang, L., Yu, J., & Wang, M. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1516878 · Cited by 25
Chen, Y., Wu, L.-K., Lee, M.-S., & Kung, Y. (2021) · Complementary Medicine Research · doi:10.1159/000513655 · Cited by 18
Chu, L., Zhu, P., Ma, C., Pan, L., Shen, L., Wu, D., Wang, Y., & Yu, G. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2021.813305 · Cited by 23
Zavadenko, N. N., Suvorinova, N. Y., Batysheva, T. T., Быкова, О. В., Platonova, A. N., Gaynetdinova, D. D., Levitina, E. V., MASHIN, V. V., Vakula, I. N., & Евгеньевна, М. Н. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212204175 · Cited by 64
Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
Boesen, K., Paludan‐Müller, A. S., Gøtzsche, P. C., & Jørgensen, K. J. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012857.pub2 · Cited by 38
ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives
Bogdańska-Chomczyk, E., Majewski, M. K., & Kozłowska, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211020 · Cited by 15
“A systematic review by Catalá-López et al. [180] supports their efficacy in children, though evidence in adults remains less conclusive.”
Jennum, P., Sørensen, A. V., Baandrup, L., Ibsen, M., Ibsen, R., & Kjellberg, J. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.01.016 · Cited by 15
Chaparro, X. D. L. M. C. (2022) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2022.08.001 · Cited by 48
Aggensteiner, P.-M., Albrecht, B., Strehl, U., Wörz, S., Ruckes, C., Freitag, C. M., Rothenberger, A., Gevensleben, H., Millenet, S., Hohmann, S., et al. (2021) · Biological Psychology · doi:10.1016/j.biopsycho.2021.108169 · Cited by 18
Attention Deficit Hyperactivity Disorder and Associated Cognitive Dysfunction in Pediatric Epilepsy
Vidaurre, J. A., & Twanow, J. E. (2017) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2017.10.009 · Cited by 18
Bruton, A. M., Nauman, J., Hanes, D. A., Gard, M., & Senders, A. (2021) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2020.0432 · Cited by 19
Nagy, N., Amin, G. R., Khalil, S. A., Mahmoud, D. A. M., Elkholy, H. A., & Shohdy, M. M. A. (2022) · Middle East Current Psychiatry · doi:10.1186/s43045-022-00210-3 · Cited by 16
Musella, K. E., & Weyandt, L. L. (2022) · Applied Neuropsychology Child · doi:10.1080/21622965.2022.2119142 · Cited by 18
Complementary and Integrative Treatments for Attention-Deficit/Hyperactivity Disorder in Youth
Russell, D., & Arnold, L. E. (2023) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.08.005 · Cited by 15
Meppelink, R., de Bruin, E. I., Zoller, B. K., Oort, F. J., & Bögels, S. M. (2024) · Mindfulness · doi:10.1007/s12671-024-02305-w · Cited by 19
Mosseri, J., Trinquart, L., Nizard, R., & Ravaud, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146336 · Cited by 15
Does Methylphenidate Work in Children and Adolescents with Attention Deficit Hyperactivity Disorder?
Ribeiro, J. P., Arthur, E. J., Gluud, C. N., Simonsen, E. H., & Storebø, O. J. (2021) · Pediatric Reports · doi:10.3390/pediatric13030050 · Cited by 21
Ward, C. L., Childress, A. C., Jin, N., Turkoglu, O., Skubiak, T., & Wilens, T. E. (2025) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2025.06.023 · Cited by 17
Catalá-López, F., Ridao-López, M., Núñez-Beltrán, A., Gènova-Maleras, R., Alonso‐Arroyo, A., Aleixandre‐Benavent, R., Catalá, M. A., & Tabarés‐Seisdedos, R. (2019) · Systematic Reviews · doi:10.1186/s13643-019-0967-y · Cited by 18
Self-citationRoy, S., Mandal, N., Ray, A., Roy, P. K., Bhattacharyya, A., & Saha, P. K. (2022) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2022.103133 · Cited by 20
Tavakoulnia, A., Guzman, K., Cibrian, F. L., Lakes, K. D., Hayes, G., & Schuck, S. E. B. (2019) · Adjunct Proceedings of the 2019 ACM International Joint Conference on Pervasive and Ubiquitous Computing and Proceedings of the 2019 ACM International Symposium on Wearable Computers · doi:10.1145/3341162.3343819 · Cited by 18
Caselles‐Pina, L., Sújar, A., Quesada‐López, A., & Delgado‐Gómez, D. (2023) · Brain and Behavior · doi:10.1002/brb3.3265 · Cited by 14
Efficacy and Safety of Centanafadine for ADHD Treatment in Children: A Randomized Clinical Trial
Ward, C. L., Wilens, T. E., Jin, N., Turkoglu, O., Skubiak, T., & Childress, A. C. (2025) · Pediatrics Open Science · doi:10.1542/pedsos.2024-000349 · Cited by 14
França, A. P., Takahashi, R. N., Cunha, R. A., & Prediger, R. D. (2018) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2018.0016 · Cited by 14
Executive function training for children with attention-deficit/hyperactivity disorder
Rapport, M. D., Eckrich, S. J., Calub, C. A., & Friedman, L. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815755-8.00008-3 · Cited by 14
Wymbs, F. A., Wymbs, B. T., Margherio, S. M., & Burd, K. A. (2021) · Journal of Child and Family Studies · doi:10.1007/s10826-020-01880-5 · Cited by 17
Visual intervention in early onset visual impairment: A review
Micheletti, S., Merabet, L. B., Galli, J., & Fazzi, E. M. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15841 · Cited by 15
Integrative proteomics and pharmacogenomics analysis of methylphenidate treatment response
da Silva, B. S., Leffa, D. T., Beys-da-Silva, W. O., Torres, I. L. S., Rovaris, D. L., Victor, M. M., Rohde, L. A., Mota, N. R., Oliveira, C. D., Berger, M., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0649-5 · Cited by 12
Gurka, M. J., Siddiqi, S. U., Filipp, S. L., Mercado, R., Thompson, L. A., Janicke, D. M., & Shenkman, E. A. (2020) · Pediatric Obesity · doi:10.1111/ijpo.12738 · Cited by 11
Poddar, A., Gaddam, S., Sonnaila, S., Bhavaraju, V. S. M., & Agrawal, S. (2025) · NeuroSci · doi:10.3390/neurosci6020041 · Cited by 18
Flores, J., Caqueo‐Urízar, A., López, V., & Acevedo, D. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-03714-8 · Cited by 22
Natural products of relevance in the management of attention deficit hyperactivity disorder
Custódio, L. M. B., Vizetto‐Duarte, C., Cebeci, F., Özçelik, B., Sharopov, F. S., Gürer, E. S., Kumar, M., Iriti, M., Sharifi‐Rad, J., & Călina, D. C. (2022) · eFood · doi:10.1002/efd2.57 · Cited by 12
Stories of Hope: Young People’s Personal Narratives About ADHD Put Into Context of Positive Aspects
Grønneberg, S. V., Engebretsen, E., & Løkkeberg, S. T. (2023) · Qualitative Health Research · doi:10.1177/10497323231206936 · Cited by 17
Kaalund-Brok, K., Houmann, T., Hebsgaard, M. B., Lauritsen, M.-B. G., Lundstrøm, L. H., Grønning, H., Darling, L., Reinert-Petersen, S., Petersen, M. A., Jepsen, J. R. M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253727 · Cited by 15
Effects of Methylphenidate on the Dopamine Transporter and Beyond
Zetterström, T., Quansah, E., & Grootveld, M. C. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_333 · Cited by 13
Experiences of neurofeedback therapists in treating attention-deficit hyperactivity disorder
Oliveira, J., Pellow, J., Tsele-Tebakang, T., & Solomon, E. M. (2022) · Health SA Gesondheid · doi:10.4102/hsag.v27i0.1874 · Cited by 12
Dort, M., Strelow, A. E., Schwinger, M., & Christiansen, H. (2020) · International Journal of Disability Development and Education · doi:10.1080/1034912x.2020.1843142 · Cited by 19
Multimodal Interventions Are More Effective in Improving Core Symptoms in Children With ADHD
Ning, K., & Wang, T. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.759315 · Cited by 19
Ahlberg, R., Garcia‐Argibay, M., Rietz, E. D., Butwicka, A., Cortese, S., D'Onofrio, B. M., Ludvigsson, J. F., & Larsson, H. (2023) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2023.03.015 · Cited by 13
Ichikawa, H., Miyajima, T., Yamashita, Y., Fujiwara, M., Fukushi, A., & Saito, K. (2020) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2019.0076 · Cited by 13
Alves, A. G. P., Cruvinel, B. A. C., Schincaglia, R. M., Godoi, L. S., & Silva, M. S. (2021) · Nutrition · doi:10.1016/j.nut.2021.111296 · Cited by 15
Kawai, C., Mori, K., Tanioka, T., Betriana, F., Mori, K., Mori, T., & Ito, H. (2021) · The Journal of Medical Investigation · doi:10.2152/jmi.68.53 · Cited by 11
Yang, K.-H., Lane, H., Chang, Y., & Tzang, R. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab034 · Cited by 17
Catalá-López, F., & Hutton, B. (2018) · Anales de Pediatría · doi:10.1016/j.anpedi.2017.12.015 · Cited by 10
Self-citationDietary and Micronutrient Treatments for Children with Neurodevelopment Disorders
Taylor, M. R., Chuang, C.-C., Carrasco, K., Nagatomo, S., & Rucklidge, J. J. (2018) · Current Developmental Disorders Reports · doi:10.1007/s40474-018-0150-5 · Cited by 12
Koonrungsesomboon, K., & Koonrungsesomboon, N. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2019.0115 · Cited by 12
BH4 as a Therapeutic Target for ADHD: Relevance to Neurotransmitters and Stress-Driven Symptoms
Wilson, S. K., & Thomas, J. (2023) · Journal of Attention Disorders · doi:10.1177/10870547231204012 · Cited by 10
Zheng, Y., Liu, H., Wang, X., Li, H., Ruhmann, M., Mayer, A., Dangel, O., & Ammer, R. (2024) · CNS Drugs · doi:10.1007/s40263-024-01136-6 · Cited by 10
Wu, G., He, Q., Li, D., Zhang, Z., Miao, J., & Shu, Y. (2024) · Brain and Behavior · doi:10.1002/brb3.70194 · Cited by 13
Kouhbanani, S. S., & Rothenberger, A. (2021) · Sustainability · doi:10.3390/su13116210 · Cited by 11
Wilkes‐Gillan, S., Cordier, R., Chen, Y.-W. R., Swanton, R., Mahoney, N., Trimboli, C., Yule, E., & Tam, E. (2021) · Australian Occupational Therapy Journal · doi:10.1111/1440-1630.12747 · Cited by 13
Mauche, N., Ulke, C., Huang, J., Franke, A., Bogatsch, H., Ethofer, T., Grimm, O., Frodl, T., Hoffmann, K., Juckel, G., et al. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01652-4 · Cited by 9
Negev Bedouin Teachers’ Attitudes Toward ADHD and Its Pharmacological Treatment
Fleischmann, A., & Dabbah, S. (2018) · Qualitative Health Research · doi:10.1177/1049732318803892 · Cited by 9
Kikuchi, D., Obara, T., Tokunaga, M., Shiozawa, M., Takahashi, A., Ito, M., Hino, H., Miura, R., Hayakawa, S., & Watanabe, Y. (2021) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2020.102512 · Cited by 9
Designing VR Games with Gaze Control for Directing Attention of Children with ADHD
Graf, L., Scholemann, L., & Masuch, M. (2021) · IEEE Conference on Games (CoG) · doi:10.1109/cog52621.2021.9619077 · Cited by 9
Preempting the Development of Antisocial Behavior and Psychopathic Traits.
Junewicz, A., & Billick, S. B. (2021) · PubMed · doi:10.29158/jaapl.200060-20 · Cited by 14
Shrestha, S., Varghese, S., Mehta, S., & Dev, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1529115 · Cited by 10
Quintero, J., Rodríguez-Quiroga, A., Álvarez-Mon, M. Á., Mora, F., & Rostain, A. L. (2022) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.03.007 · Cited by 10
Jiménez, D. R., Boreu, Q. F., Juvanteny, E. P., & Munuera, E. I. (2022) · Health Psychology and Behavioral Medicine · doi:10.1080/21642850.2022.2148672 · Cited by 14
An updated safety review of the current drugs for managing ADHD in children
Ryst, E., & Childress, A. C. (2023) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2023.2271392 · Cited by 9
Are the effects of methylphenidate uncertain?
Cortese, S. (2018) · Irish Journal of Psychological Medicine · doi:10.1017/ipm.2018.16 · Cited by 9
David, D. O., Dobrean, A., Poetar, C.-R., Iftene, F., Lupu, V., Predescu, E., & Döpfner, M. (2020) · Cognitive Therapy and Research · doi:10.1007/s10608-020-10157-6 · Cited by 9
Chen, S., Yu, J., Suen, L. K. P., Sun, Y., Pang, Y. Z., Wang, D. D., Zhao, W.-X., & Yeung, W. (2020) · Pilot and Feasibility Studies · doi:10.1186/s40814-020-00704-z · Cited by 8
Wang, F., Wen, F., Yu, L., Yan, J., Liu, J., Li, Y., & Cui, Y. (2021) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000349 · Cited by 7
Hinkelmann, J. V., Possa, L. D. O., de Oliveira, C. A., Faria, B. S., Hermsdorff, H. H. M., & Rosa, C. D. O. B. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.05.023 · Cited by 12
Russell, A. E., Dunn, B. D., Hayes, R. A., Moore, D. A., Kidger, J., Sonuga-Barke, E. J. S., Pfiffner, L. J., & Ford, T. J. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-065176 · Cited by 12
Mao, F., Liu, Z., Fang, Q., & Liu, Y. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07607-4 · Cited by 13
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Storm, M. R. O., Ribeiro, J. P., Skoog, M., Groth, C., Edemann-Callesen, H., Schaug, J. P., Darling, P. J., Huus, C.-M. L., Zwi, M., et al. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub4 · Cited by 15
de Ramón, I., Pacios, J., Medina, R., Bouhaben, J., Cuesta, P., Antón‐Toro, L. F., Quintero, J., Ramos‐Quiroga, J. A., & Maestú, F. (2022) · Brain Communications · doi:10.1093/braincomms/fcac038 · Cited by 8
Is homeopathy effective for attention deficit and hyperactivity disorder? A meta-analysis
Gaertner, K., Teut, M., & Walach, H. (2022) · Pediatric Research · doi:10.1038/s41390-022-02127-3 · Cited by 8
RetractedGudka, R., Becker, K., Newlove‐Delgado, T., & Price, A. (2024) · BMC Digital Health · doi:10.1186/s44247-024-00129-1 · Cited by 7
Can response to ADHD medication be predicted?
Lilja, M. M., Lichtenstein, P., Serlachius, E., Bhagia, J., Malmberg, K., Malm, C., Lenhard, F., & Halldner, L. (2025) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-025-02650-8 · Cited by 9
Bao, S., Wen, J. M., Lin, Q., Li, Y., Huang, Y., Zhou, H.-Y., & Hu, G. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13081 · Cited by 7
Pelagic deep-sea fauna observed on video transects in the southern Norwegian Sea
Neitzel, P., Hosia, A., Piatkowski, U., & Hoving, H. (2021) · Polar Biology · doi:10.1007/s00300-021-02840-5 · Cited by 7
Do attention-deficit/hyperactivity symptoms influence treatment outcome in gambling disorder?
Vintró‐Alcaraz, C., Mestre‐Bach, G., Granero, R., Gómez‐Peña, M., Moragas, L., Fernández‐Aranda, F., Potenza, M. N., & Jiménez‐Múrcia, S. (2023) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2023.152433 · Cited by 8
LEVIN, F. R., Mariani, J. J., Pavlicová, M., Choi, C. J., Basaraba, C. N., Mahony, A. L., Brooks, D. J., Brezing, C., & Naqvi, N. H. (2024) · Journal of Attention Disorders · doi:10.1177/10870547241264675 · Cited by 8
Zhao, F.-Y., Xu, Y., Kennedy, G. A., Conduit, R., Zhang, W., Jiang, T., Xu, P., Ho, J. Y. S., Fu, Q.-Q., & Chow, C. M. (2025) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2025.103163 · Cited by 10
Neurofeedback for ADHD: Exploring the Role of Quantitative EEG and Brainwave Modulation
Ölçüoğlu, R. (2025) · Brain and Behavior · doi:10.1002/brb3.70714 · Cited by 8
Hansen, A. S., Telléus, G. K., Jensen, C. M., Færk, E., & Lauritsen, M. B. (2022) · Clinical Child Psychology and Psychiatry · doi:10.1177/13591045221081384 · Cited by 6
Søndergaard, N. R., Nørøxe, K. B., Carlsen, A. H., Randing, S. H., Warrer, P., Thomsen, P. H., & Clausen, L. (2024) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2023.0077 · Cited by 7
Effects of stimulant treatment on sleep in attention deficit hyperactivity disorder (ADHD)
Sanabra, M., Gómez-Hinojosa, T., Alcover, C., Sans, O., & Alda, J. A. (2020) · Sleep and Biological Rhythms · doi:10.1007/s41105-020-00289-3 · Cited by 9
Chou, W., Hsiao, R. C.-J., & Yen, C. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19159505 · Cited by 10
Dutta, C. N., Christov‐Moore, L., Ombao, H., & Douglas, P. K. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.938501 · Cited by 10
Terao, I., Kodama, W., & Tsuda, H. (2023) · Journal of Attention Disorders · doi:10.1177/10870547231214988 · Cited by 6
Fernandes, P. D. A., Fontes, M. D. L., Nunes, L. O. C., Aragão, Á. F. L., Salvador, L., Sarah, T. R. B., Filho, N. A. S., & Barud, H. D. S. (2025) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2025.128177 · Cited by 7
Chiu, H., Sun, C., Cheng, Y., Wang, M. Y., Tzang, R., Lin, F.-L., Cheng, Y., & Chung, W. (2023) · European Psychiatry · doi:10.1192/j.eurpsy.2023.11 · Cited by 6
Robertz, A.-C., Törnhage, C., Nilsson, S., Nyman, V., & Kantzer, A. (2024) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2024.101909 · Cited by 7
Food Color Additives in the US Food Supply: Review of Neurobehavioral Safety
Craig, L. G., Kim, P. J., & Parker Julia, M. (2020) · Journal of Pediatric Neurology and Neuroscience · doi:10.36959/595/409 · Cited by 6
Elton, A., Allen, J. M., Yorke, M., Khan, F. A., Lin, Q., & Boettiger, C. A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.672863 · Cited by 6
Metadata
- Authors
- Catalá-López, F., Hutton, B., Núñez-Beltrán, A., Page, M. J., Ridao, M., Macías Saint-Gerons, D., Catalá, M. A., Tabarés-Seisdedos, R., & Moher, D.
- Affiliations
- Universitat de València (ES)
- University of Ottawa (CA)
- University of Bristol (GB)
- Corresponding author
- Catalá-López, Ferrán
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-07-12
- Volume
- 12
- Issue
- 7
- Pages
- e0180355
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5507500
- OpenAlex
- W2735057791
- Semantic Scholar
- e66b73662b208e9cf7a659046d713a96c5f5d574
- Cited by
- 396
- References
- 102
- Citations by year
- 2026: 26 · 2025: 53 · 2024: 39 · 2023: 51 · 2022: 48 · 2021: 76 · 2020: 40 · 2019: 29 · 2018: 29 · 2017: 4
- FWCI
- 4.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Monash University Research Portal (Monash University) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, cc-by-nc)
- Funders
- Fundación Alicia Koplowitz
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Developmental and Educational Neuropsychology
- Keywords
- attention deficit hyperactivity disorder, ADHD treatment, stimulants, non-stimulant medication, methylphenidate, amphetamine, atomoxetine, guanfacine, clonidine, behavior therapy, cognitive training, neurofeedback, complementary and alternative medicine, dietary therapy, fatty acids, herbal medicine, homeopathy, physical activity, treatment efficacy, treatment acceptability, adverse events, children and adolescents
- MeSH terms
- Adolescent, Complementary Therapies, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Behavior Therapy, Central Nervous System Depressants, Child, Female, Humans, Male, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.